A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Locally Advanced (Inoperable) or Metastatic Renal Cell Carcinoma

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

CTRC Inpatient
Highlands Ranch Hospital
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Elaine Lam

Elaine Lam

Study ID

Protocol Number: 24-0745

More information available at ClinicalTrials.gov: NCT06234605

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers